๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Metastatic Malignant Skin Neoplasm

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study NCT07405086Phase 41 site๐Ÿ“ Portland OHSU Knight Cancer Institute ยท Tests: Biospecimen Collection, Immune Checkpoint Inhibitor Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Avapritinib Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors NCT05969041Phase 16 sites๐Ÿ“ Darlinghurst๐Ÿ“ Randwick๐Ÿ“ Westmead Myeloid Therapeutics ยท Tests: MT-302 (A) Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors NCT05372640Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Cancer Institute (NCI) ยท Tests: Abemaciclib, BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing Cancer Genetic Testing in Ethnic Populations NCT04475640NA2 sites๐Ÿ“ Scottsdale๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Biospecimen Collection, Genetic Testing Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study NCT06805812n/a24 sites๐Ÿ“ Aviano๐Ÿ“ Brescia๐Ÿ“ Catania Fondazione IRCCS Istituto Nazionale dei Tumori, Milano ยท Tests: Palbociclib, Ribociclib, Abemaciclib Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial NCT06500481Phase 358 sites๐Ÿ“ Phoenix๐Ÿ“ Little Rock๐Ÿ“ Encinitas NRG Oncology ยท Tests: Biospecimen Collection, Computed Tomography, Involved-Field Radiation Therapy, Lumbar Puncture, Magnetic Resonance Imagโ€ฆ Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors NCT06171750Phase 15 sites๐Ÿ“ Bethesda๐Ÿ“ Boston๐Ÿ“ Portland Ankyra Therapeutics, Inc ยท Tests: tolododekin alfa, Cemiplimab Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. NCT05727904Phase 382 sites๐Ÿ“ Birmingham๐Ÿ“ Duarte๐Ÿ“ Los Angeles Iovance Biotherapeutics, Inc. ยท Tests: Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover Period Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary NCT02828202n/a27 sites๐Ÿ“ Amiens๐Ÿ“ Annecy๐Ÿ“ Besanรงon Assistance Publique - Hรดpitaux de Paris ยท Tests: Biological, Tissular, Quality of life Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors NCT07062003NA1 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Medical Device Usage and Evaluation, Minibeam Radiation โ€ฆ Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites๐Ÿ“ Los Angeles๐Ÿ“ Rochester University of Southern California ยท Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview Integrin ฮฑvฮฒ6-targeted PET in Malignant Tumors NCT05835570n/a1 site๐Ÿ“ Wuhan Zhongnan Hospital ยท Tests: PET/CT scans The Effect of Reduced Bleomycin in Electrochemotherapy Treatment NCT06647342Phase 42 sites๐Ÿ“ Herlev๐Ÿ“ Roskilde Julie Gehl ยท Tests: Bleomycin Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial NCT07847359Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Cryoablation, Iparomlimab and Tuvonralimab, Dacarbazine, Lenvatinib A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases NCT04511013Phase 2331 sites๐Ÿ“ Birmingham๐Ÿ“ Fairhope๐Ÿ“ Mobile SWOG Cancer Research Network ยท Tests: Binimetinib, Encorafenib, Ipilimumab, Nivolumab Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer NCT05111561Phase 14 sites๐Ÿ“ Boston๐Ÿ“ Boston๐Ÿ“ Galveston National Cancer Institute (NCI) ยท Tests: BET Bromodomain Inhibitor ZEN-3694, Binimetinib, Biopsy Procedure, Biospecimen Collection, Computed Tomography A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou Chongqing Precision Biotech Co., Ltd ยท Tests: CEA-targeted CAR-T cells Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors NCT04068155NA2 sites๐Ÿ“ Grenoble๐Ÿ“ Lyon Alpha Tau Medical LTD. ยท Tests: DaRT- Diffusing Alpha-emitters Radiation Therapy An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis NCT05376878Phase 41 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Copper Cu 64-DOTA-Trastuzumab, Magnetic Resonance Imaging, Positron Emission Tomography, Trastuzumab, Trastuzumab Deruxโ€ฆ Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer NCT05746325NA1 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Digital Photography, Lumbar Puncture, Magnetic Resonance Imaging, Medical Device Usage and Evaluation, Biospecimen Collโ€ฆ Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC NCT06332755Phase 11 site๐Ÿ“ Fairfax LG Chem ยท Tests: Phase 1a: LB-LR1109, Phase 1b: LB-LR1109 and Atezolizumab Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial NCT04693377NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Cryosurgery, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer NCT06518057Phase 23 sites๐Ÿ“ San Francisco๐Ÿ“ New York๐Ÿ“ Seattle University of Washington ยท Tests: Biospecimen Collection, Computed Tomography, Electronic Health Record Review, Lumbar Puncture, Magnetic Resonance Imagiโ€ฆ A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-1607, Paclitaxel Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer NCT06910761Phase 22 sites๐Ÿ“ Duarte๐Ÿ“ Irvine City of Hope Medical Center ยท Tests: Biospecimen Collection, Craniospinal Irradiation, Electronic Health Record Review, Lumbar Puncture, Magnetic Resonance โ€ฆ SUPRAME-ACTengineยฎ IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma NCT06743126Phase 371 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Duarte Immatics US, Inc. ยท Tests: IMA203, nivolumab plus relatlimab, lifileucel, nivolumab, pembrolizumab Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer NCT04348747Phase 23 sites๐Ÿ“ Tampa๐Ÿ“ Buffalo๐Ÿ“ Charlottesville Roswell Park Cancer Institute ยท Tests: Anti-HER2/HER3 Dendritic Cell Vaccine, Pembrolizumab AMT-253 in Patients With Advanced Solid Tumours NCT06209580Phase 1, Phase 21 site๐Ÿ“ Beijing Multitude Therapeutics Inc. ยท Tests: AMT-253 for injection Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer NCT05098210Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Neoantigen Peptide Vaccine, Nivolumab, Poly ICLC, Echocardiography Test, Multigated Acquisition Scan
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy